GAGE2C activation is intricately tied to the modulation of intracellular signaling pathways that lead to its functional enhancement. The direct stimulation of adenylate cyclase by certain compounds increases the level of cyclic AMP within cells, which further activates protein kinase A. This kinase plays a pivotal role in the phosphorylation of various proteins, including GAGE2C, thereby leading to its enhanced functional state. Similarly, compounds that act as beta-adrenergic agonists also elevate cAMP levels, following a comparable activation route via protein kinase A. Furthermore, the inhibition of GSK-3 by lithium salts may indirectly influence the activation of GAGE2C, as the suppression of this kinase alters protein stabilization and localization within cellular processes. The administration of certain phosphodiesterase inhibitors also leads to an upsurge in cAMP concentrations, thereby activating PKA, which subsequently targets proteins like GAGE2C for activation. Additionally, substances that can increase intracellular calcium, either through ionophores or by activating calcium channels, set off a cascade of calcium-dependent kinases that can activate GAGE2C by modifying its phosphorylation state.
Apart from these kinase-driven mechanisms, other molecules exert their influenceon GAGE2C through diverse signaling pathways. For instance, the application of specific catechins and polyphenols can trigger cellular stress response pathways, which may indirectly lead to GAGE2C activation as part of an adaptive cellular response. In parallel, the engagement of nuclear receptors by retinoids alters gene expression patterns, potentially leading to post-translational modifications that can activate GAGE2C. Compounds that inhibit specific phosphodiesterases result in the accumulation of secondary messengers like cAMP and cGMP, which activate protein kinases capable of phosphorylating targets such as GAGE2C. Moreover, activators of sirtuin enzymes influence acetylation status within the cell, which can lead to the activation of proteins including GAGE2C.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, increasing cyclic AMP (cAMP) levels, which can lead to activation of protein kinase A (PKA). PKA phosphorylates various target proteins, which can include GAGE2C, leading to its functional activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which phosphorylates serine and threonine residues on many cellular proteins. This phosphorylation can enhance GAGE2C activity by modifying its interaction with other proteins or its localization within the cell. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, increasing intracellular calcium levels, which activates calmodulin-dependent kinases. These kinases can then activate GAGE2C by phosphorylation or through other regulatory mechanisms that depend on calcium signaling. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cell-permeable cAMP analog that activates PKA. Activated PKA then can phosphorylate substrates including GAGE2C, leading to its activation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A catechin found in green tea, this compound has been shown to influence multiple signaling pathways, including those involved in cellular stress responses. These pathways can indirectly lead to the activation of GAGE2C by initiating adaptive cellular responses. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels in cells, leading to PKA activation. PKA can then activate GAGE2C through phosphorylation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3). Inhibition of GSK-3 can activate signaling pathways that may lead to the functional activation of GAGE2C through indirect mechanisms involving protein stabilization and localization. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), leading to increased cAMP levels in cells, thus activating PKA. PKA can then target GAGE2C or its interacting partners for activation. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Capsaicin activates transient receptor potential vanilloid 1 (TRPV1) channels, leading to calcium influx and activation of downstream calcium-dependent signaling pathways that could facilitate GAGE2C activation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression through retinoic acid receptors, which can activate signaling pathways that may lead to post-translational modifications of proteins including GAGE2C, resulting in its activation. | ||||||